NDC 50090-0701-00 - Doxazosin

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC: 50090-0701
Requested NDC: 50090-0701-00
Package NDCs from labels: 50090-0701-0, 50090-0701-00
Manufacturer: A-S Medication Solutions
Effective date: 2026-10-06
Current FDA listing: Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
Label	Manufacturer	Effective date	Type
Doxazosin - A-S Medication Solutions	A-S Medication Solutions	2026-10-06	HUMAN PRESCRIPTION DRUG LABEL

FDA-Initiated Inactive NDC Indexing#

Effective, Related label table
Effective	Related label
2023-02-07	These highlights do not include all the information needed to use DOXAZOSIN TABLETS safely and effectively. See full prescribing information for DOXAZOSIN TABLETS. DOXAZOSIN tablets, for oral use Initial U.S. Approval: 1990
2023-02-07	These highlights do not include all the information needed to use DOXAZOSIN TABLETS safely and effectively. See full prescribing information for DOXAZOSIN TABLETS. DOXAZOSIN tablets, for oral use Initial U.S. Approval: 1990
2023-02-07	These highlights do not include all the information needed to use DOXAZOSIN TABLETS safely and effectively. See full prescribing information for DOXAZOSIN TABLETS. DOXAZOSIN tablets, for oral use Initial U.S. Approval: 1990
2023-01-30	These highlights do not include all the information needed to use DOXAZOSIN TABLETS safely and effectively. See full prescribing information for DOXAZOSIN TABLETS. DOXAZOSIN tablets, for oral use Initial U.S. Approval: 1990
2023-01-30	These highlights do not include all the information needed to use DOXAZOSIN TABLETS safely and effectively. See full prescribing information for DOXAZOSIN TABLETS. DOXAZOSIN tablets, for oral use Initial U.S. Approval: 1990
2023-01-30	These highlights do not include all the information needed to use DOXAZOSIN TABLETS safely and effectively. See full prescribing information for DOXAZOSIN TABLETS. DOXAZOSIN tablets, for oral use Initial U.S. Approval: 1990

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
50090-0701-0	Doxazosin	30 in 1 BOTTLE	TABLET	30		30

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
50090-0701	DOXAZOSIN TABLET [A-S MEDICATION SOLUTIONS]	28	Current NDC, Legacy NDC, 1 package rows	20240615_bfea0b5b-9354-490f-88ff-008134077d24.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
50090-0701-0	EA - Each	50090-0701	fc58bb48-b4d3-469e-a666-891821842469	1	2018-10-11

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 4 · 68 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Doxazosin	DOXAZOSIN	REMEDYREPACK INC.	30a6bb83-f91b-4c4f-a849-4f2be3735a0e	2026-08-14	Warnings, Adverse reactions	Exact identifier application number: ANDA075580 rxcui: 197626 unii: 86P6PQK0MU
Doxazosin	DOXAZOSIN	Major Pharmaceuticals	3354196f-bbcf-4bc5-94f6-e6e8e132acb1	2026-08-05	Warnings, Adverse reactions	Exact identifier application number: ANDA075580 rxcui: 197625 rxcui: 197626 rxcui: 197627 unii: 86P6PQK0MU
Doxazosin	DOXAZOSIN	A-S Medication Solutions	bfea0b5b-9354-490f-88ff-008134077d24	2026-07-16	Warnings, Adverse reactions	Exact identifier application number: ANDA075580 ndc (package): 50090-0734-1 ndc (package): 50090-0706-0 ndc (package): 50090-0734-0 ndc (package): 50090-0704-1 ndc (package): 50090-0704-0 ndc (package): 50090-0706-2 ndc (package): 50090-0701-0 ndc (package): 50090-0706-1 ndc (product): 50090-0706 ndc (product): 50090-0704 ndc (product): 50090-0734 ndc (product): 50090-0701 ndc11 (package): 50090070100 rxcui: 197625 rxcui: 197628 rxcui: 197626 rxcui: 197627 spl id: e0a4f4aa-bc96-41b9-9597-adffac970816 spl set id: bfea0b5b-9354-490f-88ff-008134077d24 unii: 86P6PQK0MU
Doxazosin	DOXAZOSIN	REMEDYREPACK INC.	71815e8f-33ed-4f36-a8ec-d4443151a9d8	2026-07-08	Warnings, Adverse reactions	Exact identifier rxcui: 197626 unii: 86P6PQK0MU
Doxazosin	DOXAZOSIN	Golden State Medical Supply, Inc.	54eeef3d-c906-37e7-e063-6294a90afca2	2026-06-23	Warnings, Adverse reactions	Exact identifier rxcui: 197625 rxcui: 197628 rxcui: 197626 rxcui: 197627 unii: 86P6PQK0MU
Doxazosin	DOXAZOSIN	REMEDYREPACK INC.	bf2f7b41-f14d-4fcd-8db3-f507ca6ff78b	2026-06-12	Warnings, Adverse reactions	Exact identifier application number: ANDA075580 rxcui: 197627 unii: 86P6PQK0MU
Doxazosin	DOXAZOSIN	REMEDYREPACK INC.	ec06f008-37a1-4757-a3ee-0b4720912bc4	2026-06-11	Warnings, Adverse reactions	Exact identifier rxcui: 197626 unii: 86P6PQK0MU
Doxazosin	DOXAZOSIN	PD-Rx Pharmaceuticals, Inc.	2ea9bb6b-a4f0-496a-b27b-4454167a4b70	2026-05-13	Warnings, Adverse reactions	Exact identifier application number: ANDA075580 rxcui: 197626 unii: 86P6PQK0MU
Doxazosin	DOXAZOSIN	Cardinal Health 107, LLC	08521333-ff21-45ad-b99e-1f43d945d24d	2026-04-24	Warnings, Adverse reactions	Exact identifier application number: ANDA075580 rxcui: 197626 unii: 86P6PQK0MU
Doxazosin	DOXAZOSIN MESYLATE	Bryant Ranch Prepack	277c3278-4fe2-47ac-9115-15b417325ffd	2026-04-13	Warnings, Adverse reactions	Exact identifier rxcui: 197627 unii: 86P6PQK0MU
Doxazosin	DOXAZOSIN	Preferred Pharmaceuticals Inc.	2110eec5-949d-4718-ad6d-3629e5db8a07	2026-04-08	Warnings, Adverse reactions	Exact identifier application number: ANDA075580 rxcui: 197627 unii: 86P6PQK0MU
Doxazosin	DOXAZOSIN	Preferred Pharmaceuticals Inc.	e046e0b7-f510-4318-9884-034d683864d4	2026-04-08	Warnings, Adverse reactions	Exact identifier application number: ANDA075580 rxcui: 197626 unii: 86P6PQK0MU
Doxazosin	DOXAZOSIN	AvPAK	de9ab9a4-d8b8-8b36-e053-2a95a90aaa35	2026-03-24	Warnings, Adverse reactions	Exact identifier application number: ANDA075580 rxcui: 197625 rxcui: 197628 rxcui: 197626 rxcui: 197627 unii: 86P6PQK0MU
Doxazosin	DOXAZOSIN	AvKARE	e3d381c1-3b2f-af70-f4e6-08d6202eed25	2026-03-24	Warnings, Adverse reactions	Exact identifier application number: ANDA075580 rxcui: 197628 rxcui: 197626 rxcui: 197627 unii: 86P6PQK0MU
Doxazosin	DOXAZOSIN MESYLATE	Bryant Ranch Prepack	e2f5d7d2-21aa-4921-8035-da945d3c565c	2026-03-04	Warnings, Adverse reactions	Exact identifier rxcui: 197627 unii: 86P6PQK0MU
Doxazosin	DOXAZOSIN	NuCare Pharmaceuticals, Inc.	54116886-ea5e-5320-e054-00144ff8d46c	2026-02-16	Warnings, Adverse reactions	Exact identifier application number: ANDA075580 rxcui: 197626 unii: 86P6PQK0MU
Doxazosin	DOXAZOSIN MESYLATE	Bryant Ranch Prepack	8641cdb1-dc16-4a13-8a84-bc8f6d58b4d4	2026-02-13	Warnings, Adverse reactions	Exact identifier rxcui: 197626 unii: 86P6PQK0MU
Doxazosin	DOXAZOSIN	Bryant Ranch Prepack	54549d19-6311-4dbb-8622-fd3e5440551a	2026-01-29	Warnings, Adverse reactions	Exact identifier application number: ANDA075580 rxcui: 197627 unii: 86P6PQK0MU
Doxazosin	DOXAZOSIN	Northwind Health Company, LLC	f2b35586-d550-3fcb-e053-2995a90a3403	2026-01-19	Warnings, Adverse reactions	Exact identifier rxcui: 197627 unii: 86P6PQK0MU
Doxazosin	DOXAZOSIN MESYLATE	Northwind Health Company, LLC	f6c9856e-9154-f349-e053-6294a90a9f2c	2026-01-19	Warnings, Adverse reactions	Exact identifier rxcui: 197627 unii: 86P6PQK0MU

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.